Jacob Rajfer

Q: What Schools Are Affiliated With Jacob Rajfer

Jacob Rajfer is affiliated with the following schools: University of California, Los Angeles, University of Washington

Jacob Rajfer's AcademicInfluence.com Rankings

Jacob Rajfer

Medical

#2664

World Rank

#3095

Historical Rank

Urology

#17

World Rank

#18

Historical Rank

Pharmacology

#288

World Rank

#337

Historical Rank

medical Degrees

Jacob Rajfer

Philosophy

#7641

World Rank

#10882

Historical Rank

Logic

#4688

World Rank

#6009

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Jacob Rajfer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jacob Rajfer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. (1990) (829)
Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission (1992) (638)
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. (1999) (601)
Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. (1992) (409)
Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. (1999) (389)
Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat. (1995) (261)
L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. (2003) (203)
Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. (2006) (202)
Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. (1995) (193)
The efficacy and safety of tadalafil: an update (2004) (186)
Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. (1992) (185)
Antifibrotic role of inducible nitric oxide synthase. (2002) (164)
Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease (2005) (160)
Chronic daily tadalafil prevents the corporal fibrosis and veno‐occlusive dysfunction that occurs after cavernosal nerve resection (2007) (158)
Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. (2004) (155)
Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. (2002) (153)
Hormonal regulation of testicular descent: experimental and clinical observations. (1977) (150)
Effect of aging on nitric oxide-mediated penile erection in rats. (1995) (150)
Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. (2003) (144)
Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. (1996) (134)
Peyronie's Disease: A Review. (2003) (134)
Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats (2008) (131)
Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. (1997) (131)
Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. (2002) (131)
Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. (2003) (130)
Role of the gubernaculum and intraabdominal pressure in the process of testicular descent. (1984) (130)
Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. (1993) (121)
Treatment with finasteride following radical prostatectomy for prostate cancer. (1995) (120)
Effects of long‐term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease (2006) (120)
Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease (2003) (114)
Effect of muscle‐derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat (2008) (114)
Sex steroid imprinting of the immature prostate. Long-term effects. (1978) (114)
Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US (2007) (114)
Effect of long-term passive smoking on erectile function and penile nitric oxide synthase in the rat. (1997) (113)
Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass (2006) (113)
Current treatment options for penile fractures. (2004) (112)
Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone. (1986) (108)
Inhibition of testicular testosterone biosynthesis following experimental varicocele in rats. (1987) (108)
Restoration of normal adult penile erectile response in aged rats by long-term treatment with androgens. (1995) (106)
Prevalence of corporeal venous leakage in impotent men. (1988) (106)
A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil. (2004) (104)
Cloning of a novel neuronal nitric oxide synthase expressed in penis and lower urinary tract. (1996) (102)
Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. (2009) (102)
Helical CT angiography for examination of living renal donors. (1997) (101)
Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media. (2004) (98)
Treatment of interstitial cystitis with a quercetin supplement. (2001) (88)
In vitro inhibition of testosterone biosynthesis by ketoconazole. (1985) (88)
Pioglitazone prevents corporal veno‐occlusive dysfunction in a rat model of type 2 diabetes mellitus (2006) (87)
Long-Term Continuous Treatment with Sildenafil Ameliorates Aging-Related Erectile Dysfunction and the Underlying Corporal Fibrosis in the Rat1 (2007) (87)
Improvement in emotional well-being and relationships of users of sildenafil. (2001) (85)
Effects of neonatal steroids on male sex tissues. (1979) (85)
Evidence That Osteogenic Progenitor Cells in the Human Tunica Albuginea May Originate from Stem Cells: Implications for Peyronie Disease1 (2005) (84)
The incidence of intersexuality in patients with hypospadias and cryptorchidism. (1976) (83)
Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction. (2008) (82)
Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy (2010) (81)
Effects of long-term oral administration of L-arginine on the rat erectile response. (1997) (81)
Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. (1990) (79)
Gene Transfer of Inducible Nitric Oxide Synthase Complementary DNA Regresses the Fibrotic Plaque in an Animal Model of Peyronie's Disease1 (2004) (77)
The evolving role of testosterone in the treatment of erectile dysfunction (2006) (77)
Aging-Related Increased Expression of Inducible Nitric Oxide Synthase and Cytotoxicity Markers in Rat Hypothalamic Regions Associated with Male Reproductive Function (2001) (75)
Management of the postpubertal cryptorchid testis: a statistical review. (1985) (74)
Gene expression in Peyronie's disease (2002) (72)
Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis (2002) (70)
Synergy of abdominal pressure and androgens in testicular descent. (1983) (69)
Gene expression profiles in the Peyronie's disease plaque. (2002) (69)
Aging-Related Expression of Inducible Nitric Oxide Synthase and Markers of Tissue Damage in the Rat Penis1 (2001) (67)
Gene Therapy of Erectile Dysfunction in the Rat with Penile Neuronal Nitric Oxide Synthase1 (2002) (66)
The role of nitric oxide in erectile function. (1995) (63)
Mechanism of inhibition of human testicular steroidogenesis by oral ketoconazole. (1986) (63)
Intraurethral prostaglandin E-2 cream: a possible alternative treatment for erectile dysfunction. (1993) (60)
Presence of NMDA receptor subunits in the male lower urogenital tract. (2000) (60)
Association between abdominal wall defects and cryptorchidism. (1986) (60)
The pleiotropic effects of inducible nitric oxide synthase (iNOS) on the physiology and pathology of penile erection. (2005) (60)
Up-regulation of the levels of androgen receptor and its mRNA by androgens in smooth-muscle cells from rat penis (1993) (60)
Cavernosal nerve stimulation in the rat reverses castration-induced decrease in penile NOS activity. (1996) (58)
Anatomy of penile venous drainage in potent and impotent men during cavernosography. (1989) (58)
Identification, partial characterization and age-related changes of a cytoplasmic androgen receptor in the rat penis. (1980) (58)
Molecular pathophysiology and gene therapy of aging-related erectile dysfunction (2004) (57)
MUSE therapy: preliminary clinical observations. (1997) (55)
Profibrotic role of myostatin in Peyronie's disease. (2008) (55)
Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review (2008) (54)
Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction (2009) (54)
Experimental models of Peyronie's disease. Implications for new therapies. (2009) (53)
Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque. (2005) (53)
Antisense and short hairpin RNA (shRNA) constructs targeting PIN (Protein Inhibitor of NOS) ameliorate aging-related erectile dysfunction in the rat. (2007) (50)
Gene Therapy of Erectile Dysfunction in the Rat with Penile Neuronal Nitric Oxide Synthase1 (2002) (50)
Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat. (2011) (47)
Aging related erectile dysfunction—potential mechanism to halt or delay its onset (2017) (47)
Cyclosporine inhibits testosterone biosynthesis in the rat testis. (1987) (47)
Long-term results of penile vein ligation for impotence from venous leakage. (1993) (47)
Effects of cyclosporine on the hypothalamic-pituitary-gonadal axis in the male rat: mechanism of action. (1988) (47)
Carcinoid tumor of the kidney: case report and review of the literature. (2005) (47)
Recovery of testicular blood flow following ligation of testicular vessels. (1989) (46)
Expression of inducible nitric oxide synthase in smooth muscle cells from rat penile corpora cavernosa. (1995) (46)
Dysgenetic male pseudohermaphroditism. (1978) (46)
Corporal veno-occlusive dysfunction in aging rats: evaluation by cavernosometry and cavernosography. (2004) (45)
The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes. (2010) (45)
Correlation between penile angiography and duplex scanning of cavernous arteries in impotent men. (1990) (43)
Placenta percreta and the urologist. (2009) (43)
Adrenal control of erectile function and nitric oxide synthase in the rat penis. (1997) (43)
Relationship between testosterone and erectile dysfunction. (2000) (42)
Expression of the androgen receptor gene in rat penile tissue and cells during sexual maturation. (1991) (42)
Use of biopty gun for transcutaneous testicular biopsies. (1989) (42)
Surveillance of patients with bladder carcinoma using fluorescent in‐situ hybridization on bladder washings (2007) (41)
Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage. (2012) (41)
Long-Term Continuous Treatment with Sildenafil Ameliorates Aging-Related Erectile Dysfunction and the Underlying Corporal Fibrosis in the Rat (2007) (41)
Characterization of cyclic nucleotide and inositol 1,4,5-trisphosphate-sensitive calcium-exchange activity of smooth muscle cells cultured from the human corpora cavernosa. (1988) (39)
Testosterone down-regulates the levels of androgen receptor mRNA in smooth muscle cells from the rat corpora cavernosa via aromatization to estrogens (1993) (38)
Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction. (1993) (38)
Hormonal effects of ketoconazole in vivo in the male rat: mechanism of action. (1986) (37)
Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells. (2006) (37)
Results in the United States with Sperm Micro-Aspiration Retrieval Techniques and Assisted Reproductive Technologies (1994) (37)
The Role of Estrogen Modulators in Male Hypogonadism and Infertility. (2016) (37)
Interstitial Tamm-Horsfall protein in rejecting renal allografts. Identification and morphologic pattern of injury. (1984) (37)
Noninvasive radiological diagnosis of renal vein thrombosis in renal transplantation. (1991) (37)
Protein Inhibitor of Nitric Oxide Synthase (NOS) and the N-Methyl-d-Aspartate Receptor Are Expressed in the Rat and Mouse Penile Nerves and Colocalize with Penile Neuronal NOS1 (2003) (36)
ORAL BISPHENOL A (BPA) GIVEN TO RATS AT MODERATE DOSES IS ASSOCIATED WITH ERECTILE DYSFUNCTION, CAVERNOSAL LIPOFIBROSIS, AND ALTERATIONS OF GLOBAL GENE TRANSCRIPTION (2013) (35)
Pregnancy following insemination with sperm aspirated directly from vas deferens. (1986) (35)
Testicular histology following chronic gonadotropin-releasing hormone agonist treatment. (1984) (34)
Ketorolac-based analgesia improves outcomes for living kidney donors. (2002) (34)
Androgen deficiency in aging and metabolically challenged men. (2012) (33)
Case report: Avoidance of palpable corporal fibrosis due to priapism with upregulators of nitric oxide. (2006) (32)
Neurotransmitter identity doubt (1990) (31)
Effects of extracellular ionized calcium, diltiazem and cAMP on motility of human spermatozoa. (1989) (31)
Impaired testosterone biosynthesis in cryptorchidism. (1985) (30)
Obstructive uropathy secondary to ureteroinguinal herniation. (2001) (30)
Vein grafting of tunical incisions combined with contralateral plication in the treatment of penile curvature. (1994) (30)
Laparoscopic Versus Open Renal Procurement for Pediatric Recipients of Living Donor Renal Transplantation (2005) (29)
Lack of a direct effect of gonadotropin hormone-releasing hormone agonist on human testicular steroidogenesis. (1987) (29)
The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer. (2010) (28)
Cytomegaloviral epididymitis in a patient with the acquired immune deficiency syndrome. (1986) (28)
Reduction clitoroplasty via ventral approach. (1982) (28)
Testicular descent. (1977) (27)
Infertility in the Male (1985) (27)
Ageing‐related corpora veno‐occlusive dysfunction in the rat is ameliorated by pioglitazone (2007) (26)
Erectile Dysfunction and Essential Hypertension: The Same Aging-related Disorder? (2014) (26)
Modified venovenous bypass technique for resection of renal and adrenal carcinomas with involvement of the inferior vena cava. (1996) (26)
The use of computerized tomography scanning to localize the impalpable testis. (1983) (26)
Potency and specificity of CGS-16949A as an aromatase inhibitor. (1990) (25)
Fever and prostatic mass in a young man. (1978) (25)
Incidence of cryptorchidism. (1982) (25)
Declining incidence of wound infection in cadaveric renal transplant recipient. (1988) (24)
Endocrinological study of testicular descent in the rabbit. (1982) (23)
Is the testis a chemo-privileged site? Is there a blood-testis barrier? (2007) (23)
Penile neuronal nitric oxide synthase and its regulatory proteins are present in hypothalamic and spinal cord regions involved in the control of penile erection (2003) (23)
Association between Wilms tumor and gonadal dysgenesis. (1981) (22)
Levels of nitric oxide metabolites do not increase during penile erection. (1993) (22)
Therapy of erectile dysfunction (2004) (22)
EFFECT OF CYCLOSPORINE ON STEROIDOGENESIS IN RAT LEYDIG CELLS (1988) (22)
Implanted Muscle-Derived Stem Cells Ameliorate Erectile Dysfunction in a Rat Model of Type 2 Diabetes, but Their Repair Capacity Is Impaired by Their Prior Exposure to the Diabetic Milieu. (2016) (22)
New discoveries in the basic science understanding of Peyronie’s disease (2004) (22)
Axial penile rigidity as primary efficacy outcome during multi-institutional in-office dose titration clinical trials with alprostadil alfadex in patients with erectile dysfunction (2000) (21)
Testicular descent. Normal and abnormal. (1978) (21)
Pyelovesicostomy as a form of urinary reconstruction in renal transplantation. (1986) (21)
Polyarteritis nodosa presenting as hematuria and a testicular mass. (2001) (21)
Improved survival of en bloc renal allografts from pediatric donors. (1997) (21)
The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets. (2015) (20)
Morphological study of testicular descent in the rabbit. (1981) (19)
Prevention of seminiferous tubular atrophy in a naturally cryptorchid rat model by early surgical intervention. (1996) (19)
Diabetes and erectile dysfunction (2004) (19)
Thrombotic microangiopathy: recurrence following renal transplant and response to plasma infusion. (1982) (18)
Testosterone replacement therapy in men with prostate cancer: a time-varying analysis. (2015) (18)
Therapeutic stimulation of penile nitric oxide synthase (NOS) and related pathways. (2000) (18)
1252: Gene Therapy with the Inducible Nitric Oxide Synthase (INOS) Cdna Regresses the Fibrotic Plaque in an Animal Model of Peyronie's Disease (2004) (17)
Recurrent respiratory disease, azoospermia, and nasal polyposis. A syndrome that mimics cystic fibrosis and immotile cilia syndrome. (1985) (17)
Diagnostic and therapeutic options for the management of ischemic and nonischemic priapism. (2010) (17)
Pulmonary migration of coils inserted for treatment of erectile dysfunction caused by venous leakage. (1993) (17)
Comparison of the efficacy of subcutaneous and nasal spray buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer. (1986) (17)
Cavernosography following clinical failure of penile vein ligation for erectile dysfunction. (1990) (16)
Assay system for simultaneous measurement of three steroidogenic enzyme activities in rat and human testis--effect of human chorionic gonadotropin. (1985) (16)
Technique of orchiopexy. (1982) (16)
Transforming Growth Factor‐β1 (TGF‐β1) in Penile and Prostate Growth in the Rat During Sexual Maturation (1998) (16)
Ureteral tumor thrombus from renal cell carcinoma extending into bladder. (2007) (16)
Effects of gonadotropin-releasing hormone analogs on cis-platinum-induced spermatogenic damage. (1988) (15)
Effect of in vitro ketoconazole on steroid production in rat testis (1985) (15)
Androgens are not major down-regulators of androgen receptor levels during growth of the immature rat penis (1996) (15)
Effect of GnRH superactive analogs (alone and combined with androgen) on testicular function in man and experimental animals. (1983) (14)
Long-term effects of prepubertal testicular vessel ligation on testicular function in the rat. (1990) (14)
Effect of cryptorchidism on testicular histology in a naturally cryptorchid animal model. (1997) (14)
Surgical and hormonal therapy for cryptorchidism: an overview. (1988) (13)
Pre-embolization evaluation of high-flow priapism: magnetic resonance angiography of the penis (2013) (13)
Androgen deficiency in the etiology and treatment of erectile dysfunction. (2005) (13)
Mechanism of Inhibition of Human Testicular Steroidogenesis by Oral Ketoconazole (1987) (13)
Cyclosporine augments renal mitochondrial function in vivo and reduces renal blood flow. (1989) (13)
EFFECT OF MUSCLE DERIVED STEM CELLS ON THE RESTORATION OF CORPORA CAVERNOSA SMOOTH MUSCLE AND ERECTILE FUNCTION IN THE AGED RAT (2008) (12)
Bilateral ureteral obstruction after repair of aortic aneurysm. (1979) (12)
Amelioration of diabetes‐induced cavernosal fibrosis by antioxidant and anti‐transforming growth factor‐β1 therapies in inducible nitric oxide synthase‐deficient mice (2012) (12)
Silicate urolithiasis. (1984) (12)
The role of serum testosterone testing: routine hormone analysis is an essential part of the initial screening of men with erectile dysfunction. (2004) (12)
Effects of multiple injections of HCG on testis blood flow. (1992) (12)
Extracorporeal methods of vascular control for difficult IVC procedures. (1996) (12)
Nitric Oxide and Other Neurotransmitters of the Corpus Cavernosum (1997) (11)
A new and simplified method for concealing the hypertrophied clitoris. (1981) (11)
Effect of ginger, Paullinia cupana, muira puama and l- citrulline, singly or in combination, on modulation of the inducible nitric oxide- NO-cGMP pathway in rat penile smooth muscle cells. (2018) (11)
Chronic high dose intraperitoneal bisphenol A (BPA) induces substantial histological and gene expression alterations in rat penile tissue without impairing erectile function. (2013) (11)
Dyslipidemia Is a Major Factor in Stem Cell Damage Induced by Uncontrolled Long-Term Type 2 Diabetes and Obesity in the Rat, as Suggested by the Effects on Stem Cell Culture. (2018) (11)
Ontogeny of the cytoplasmic androgen receptor in the rat ventral prostate gland. (1980) (11)
Is repeat biopsy for isolated high-grade prostatic intraepithelial neoplasia necessary? (2007) (11)
Cardiovascular Health, Erectile Dysfunction, and Testosterone Replacement: Controversies and Correlations. (2017) (11)
Laparoscopic occlusion of testicular veins for clinical varicocele. (1992) (10)
Editorial: Impotence--The Quick Work-Up (1996) (10)
The effect of zanoterone, a steroidal androgen receptor antagonist, in men with benign prostatic hyperplasia. The Zanoterone Study Group. (1995) (10)
Effect of ketorolac on renal function after donor nephrectomy. (2002) (10)
Discovery of NO in the penis (2008) (10)
Luteinizing hormone and follicle-stimulating hormone responses to intransal gonadotropin-releasing hormone. (1986) (10)
Cavernous artery obstruction following blunt trauma to the penis. (1993) (10)
Variability of venous anatomy of rat testis: Application to experimental testicular surgery (1992) (9)
The two phases of the clinical validation of preclinical translational mechanistic research on PDE5 inhibitors since Viagra’s advent. A personal perspective (2018) (9)
Myostatin, a profibrotic factor and the main inhibitor of striated muscle mass, is present in the penile and vascular smooth muscle (2017) (9)
Inhibition of fatty acid-supported mitochondrial respiration by cyclosporine. (1990) (9)
TESA or TESE: Which Is Better for Sperm Extraction? (2006) (9)
Testicular oximetry: a new method for the assessment of tissue perfusion and viability following torsion and detorsion. (1989) (9)
Kinetics of cyclosporine A-induced inhibition of succinate-coenzyme Q dehydrogenase in rat renal cortical mitochondria. (1990) (8)
Acute bilateral renal cortical necrosis as a cause of postoperative renal failure. (2001) (8)
1608: Long-Term Treatment with High Doses of Sildenafil Does Not Up-Regulate the Levels of Phosphodiesterase 5 (Pde5) in the Rat Penis (2004) (8)
Mechanisms of, and novel pharmacological approaches to, Peyronie’s disease (2004) (8)
Decreased testosterone in the aging male: summary and conclusions. (2003) (7)
Effect of 5-alpha-reductase inhibitor, 4-MAPC, on testicular descent in male rat. (1991) (7)
Hyperprolactinemia and erectile dysfunction. (2000) (7)
Conservative management options for peyronie’s disease (2005) (7)
From the lab to the clinic. (1998) (7)
Common Problems in Infertility and Impotence (1990) (7)
Fournier's Gangrene: A Model for Early Prediction (2014) (7)
Early onset erectile dysfunction is usually not associated with abnormal cavernosal arterial Inflow (2013) (7)
Experimental Models for the Study of the Cellular and Molecular Pathophysiology of Peyronie’s Disease (2007) (7)
Varicoceles: practice guidelines. (2007) (7)
Future strategies for treating erectile dysfunction. (2002) (7)
The aging penis: what is it trying to tell us? (2012) (6)
RANDOMIZED, DOUBLE-BLIND COMPARISON OF CEFEPIME AND CEFTAZIDIME THERAPY FOR URINARY TRACT INFECTION (1995) (6)
CHARACTERIZATION OF ENDOGENOUS STEM CELLS FROM THE MOUSE PENIS THAT EXPRESS AN EMBRYONIC STEM CELL GENE AND UNDERGO DIFFERENTIATION INTO SEVERAL CELL LINEAGES (2009) (6)
Identification of motile sperm in caput epididymis. Intraoperative observations and clinical correlations. (1992) (6)
The L-arginine-nitric oxide-cyclic GMP pathway mediates inhibitory nonadrenergic-noncholinergic neurotransmission in the corpus cavernosum of human and rabbit (1993) (6)
Safety and efficacy of daily Revactin® in men with erectile dysfunction: a 3-month pilot study (2018) (6)
Rising PSA during Testosterone Replacement Therapy. (2004) (6)
A PROTEIN INHIBITOR OF NOS (PIN) IS EXPRESSED IN THE RAT AND MOUSE PENILE NERVES AND CO-LOCALIZES WITH PENILE NEURONAL NOS (PnNOS) (1999) (6)
Endothelial dysfunction as a cause of erectile dysfunction--misdiagnosis or misnomer? (2004) (6)
PRO-FIBROTIC ROLE OF MYOSTATIN IN PEYRONIE'S DISEASE (2008) (5)
Effects of hormones in the newborn period on the development of the penis. (1977) (5)
UCLA conference. Infertility in the male. (1985) (5)
994: Reduction of the Fibrotic Plaque in a Rat Model of Peyronie's Disease by Long-Term PDE5 Inhibition (2006) (5)
Hormonal regulation of testicular descent (2004) (5)
Impotence--the quick work-up. (1996) (5)
Transforming growth factor-beta1 (TGF-beta1) in penile and prostate growth in the rat during sexual maturation. (1998) (5)
Decreased Testosterone in the Aging Male (2003) (4)
Role of fibrin in the development of surgical adhesions. (2005) (4)
Effects of chronic D-Leu6, des-Gly10-gonadotropin releasing hormone ethylamide on male sex tissues. (1984) (4)
1060: Tadalafil does not Up-Regulate the Expression and Activity of Phosphodiesterase 5 (PDE-5) in the Penis (2005) (4)
Growth factors and gene therapy for erectile dysfunction. (2000) (4)
Is the race not always to the swift? (1982) (4)
1420: Detrimental Effect of Cigarette Smoking on Erectile Dysfunction in the Rat is Contingent to Diabetes as Co-Morbidity (2004) (4)
Extrinsic bladder compression caused by a pubic bone spur. (1999) (4)
1428: Osteogenic Progenitor Cells in the Peyronie's Disease Plaque may be Responsible for Plaque Ossification (2004) (3)
Ontogeny of 5α-Reductase and the Androgen Receptor in the Penis (1981) (3)
Opportunities and challenges in oral therapy (2000) (3)
Peyronie's disease: a review. (2003) (3)
The current role of pre-transplant blood transfusions and tissue typing in cadaveric renal transplantation. (1987) (3)
1061: Effect of Bilateral Cavernosal Nerve Resection on the Histological Alterations in the Penile Vascular System (2005) (3)
Kidney transplantation at UCLA. (2002) (3)
Case scenario: 26-year-old male with right scrotal pain and swelling. (2002) (3)
Premature ejaculation: prevalent but poorly understood. (2000) (3)
SEVERE HYPERGLYCEMIA, RENAL DAMAGE, AND LOW SERUM TESTOSTERONE ARE INSUFFICIENT IN THE ABSENCE OF OBESITY TO CAUSE CORPORAL VENO-OCCLUSIVE DYSFUNCTION (CVOD) IN A RAT MODEL OF TYPE 2 DIABETES (2009) (2)
Effect of the antiandrogen, WIN 49,596, on the descent of the testis in the male rat. (1991) (2)
Percutaneous sperm aspiration of a spermatocele for intracytoplasmic sperm injection. (1997) (2)
Sperm health in the aging male. (2006) (2)
Prescribing PDE5 Inhibitors: Who Is the "Normal" Man? (2002) (2)
Techniques and reasons to remain interested in the Y chromosome. (2006) (2)
Gonadoblastoma: unusual presentation in a patient lacking persistent müllerian ducts. (1987) (2)
Conservative management of a grade 4 renal laceration in a child. (2001) (2)
Exogenous l-ARGININE does not stimulate production OF NO or cGMP within the rat corporal smooth muscle cells in culture. (2019) (2)
1437: Phosphodiesterase 4 (PDE4) is Expressed in the Normal Tunica Albuginea and in the Peyronie's Disease Plaque (2004) (2)
Ontogeny of androgen receptor in penis. (1979) (2)
Enhancement of sperm motility in assisted reproduction. (2006) (2)
Androgen replacement and quality of life. (2003) (2)
Book ReviewProstate Cancer (1985) (2)
EXPRESSION OF PENILE NEURONAL NITRIC OXIDE SYNTHASE (PnNOS) IN THE RAT AND MOUSE PENILE NERVES (1999) (2)
Successful surgical treatment of cryptorchidism in the Long-Evans cryptorchid rat model (1994) (2)
1248: Myostatin is Expressed in the Normal Tunica Albuginea and Peyronie's Fibrotic Plaque in Parallel to Myofibroblast Differentiation (2004) (2)
To Treat Hepatic Coma in Malignancy (1971) (1)
Selective serotonin reuptake inhibitors cause erectile dysfunction: true or false? (2009) (1)
Pomegranate juice: is it the new, all-natural phosphodiesterase type 5 inhibitor? (2008) (1)
Advances in sexual medicine: highlights from the 2007 winter meeting of the sexual medicine society of north america, december 6-9, 2007, chicago, IL. (2008) (1)
Hypertension: The Link Between Erectile Dysfunction and Coronary Artery Disease (2013) (1)
Effect of testis biopsy on testosterone production. (2005) (1)
Diagnostic index and dysfunction treatment. (2000) (1)
Primary Care Evaluation and Treatment of Erectile Dysfunction (2012) (1)
Peyronie’s Disease: Pathophysiology and Medical Therapy (2004) (1)
Best of the 2007 AUA Annual Meeting: Highlights from the 2007 Annual Meeting of the American Urological Association, May 19-24, 2007, Anaheim, CA. (2007) (1)
Infection patterns in cyclosporine-treated cadaveric renal transplant patients. (1988) (1)
Timing of sperm harvesting: is there room for improvement? (2008) (1)
Percutaneous Epididymal Sperm Aspiration: The Procedure of Choice for Sperm Harvesting in Patients With Obstructive Azoospermia. (2001) (1)
781: Time Course of Corporal Vend-Occlusive Dysfunction (CVOD) Development and Inducible Nitric Oxide Synthase (INOS) Expression in Rat Penile Tissue after Cavernosal Nerve Damage (2007) (1)
1045: Pioglitazone Ameliorates Penile Corpora Veno-Occlusive Dysfunction (CVOD) in a Rat Model of Type 2 Diabetes (2005) (1)
1126 LONG-TERM DAILY LOW DOSES OF SILDENAFIL, MOLSIDOMINE, AND CORPORAL IMPLANTATION OF MUSCLE DERIVED STEM CELLS (MDSC), ALONE OR IN COMBINATION, PREVENT CORPORAL VENOOCLUSIVE DYSFUNCTION (CVOD) IN A RAT MODEL OF CAVERNOSAL NERVE DAMAGE (2011) (1)
821 BISPHENOL A ADMINISTERED ORALLY AT MODERATE DOSES INDUCES ERECTILE DYSFUNCTION AND CAVERNOSAL LIPO-FIBROSIS IN RATS (2013) (1)
Sildenafil improved erections and increased successful sexual intercourse in diabetic men with erectile dysfunction (1999) (1)
Early improvement in SHIM scores with Revactin® (2019) (1)
1071: Alterations of the Corpora Cavernosa Associated with Aging and Veno-Oclussive Dysfunction in the Rat (2005) (1)
Prolonged cold storage and the cadaveric kidney transplant recipient. (1989) (1)
GENETIC BLOCKADE OF INDUCIBLE NITRIC OXIDE SYNTHASE (INOS) INTENSIFIES THE DEVELOPMENT OF FIBROSIS IN A MOUSE MODEL OF DIABETES TYPE 1 (2009) (1)
Gene Therapy for Erectile Dysfunction (2006) (1)
Freeze that Sperm. (2006) (1)
685: A Short Hairpin RNA Targeting Pin (Protein Inhibitor of NOS) is More Efficient than the Anti-Sense Pin RNA for Gene Therapy of Aging-Related Erectile Dysfunction in the RAT (2007) (1)
Kidney transplantation at UCLA--the past 10 years. (1997) (1)
63 MYOSTATIN SHORT INTERFERING HAIRPIN RIBONUCLEIC ACID GENE TRANSFER INCREASES MUSCLE MASS AND REDUCES INTERSTITIAL CONNECTIVE TISSUE. (2006) (1)
Genetic testing of infertile patients. (2004) (0)
Contemporary Management of Impotence and InfertilityTanaghoE.A., LueT.F. and McClureR.D.: Baltimore: The Williams & Wilkins Co.1988: 386. (1989) (0)
Best of the 2008 sexual medicine society of north america: highlights from the sexual medicine society of north america, october 16-19, 2008, toronto, ontario, Canada. (2009) (0)
REVERSION OF ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY , BY MODULATION OF NITRIC (2009) (0)
Cyclosporine in cadaveric renal transplantation: a comparison of two immunosuppressive protocols. (1987) (0)
076 Exogenous Administration of L-arginine Does Not Stimulate the Endogenous NO-cGMP Pathway in Rat Penile Corpora Smooth Muscle Cells (2019) (0)
NITRICOXIDE AS A MEDIATOR OF RELAXATION OF THE CORPUS CAVERNOSUM. AUTHOR'SREPLIES (1992) (0)
Re: Benign prostatic hyperplasia and uterine leiomyomas in a female pseudohermaphrodite: a case report. (1988) (0)
Recent findings in impotence research: 10th world congress of the international society for sexual and impotence research, montreal, Canada, september 22-26, 2002. (2003) (0)
Men Undergoing ICSI: Y We Do What We Do. (2001) (0)
Effect of Cyclosporine on Serum LH in the Castrate Rat (1987) (0)
ANTIFIBROTIC AND ANTIOXIDANT THERAPIES PREVENT THE DEVELOPMENT OF FIBROSIS ASSOCIATED WITH TYPE 1 DIABETES IN THE PENILE CORPORA CAVERNOSA OF THE INOS KNOCK OUT MOUSE (2009) (0)
Effect of Radiation on Testicular Steroidogenesis in the Rat: An Endocrinologic and Histologic Analysis (1987) (0)
Activation of the iNOS/NO/cGMP pathway by Revactin® in human corporal smooth muscle cells (2021) (0)
The evaluation and management of male infertility following solid-organ transplantation. (1994) (0)
Letter to the Editor Is TESA Passé (2006) (0)
1197: AT-Home Efficacy of an Intranasally Administered Melanocortin Receptor Agonist, PT-141, In Men with Erectile Dysfunction (ED) (2004) (0)
Timing of Sperm Retrieval in ICSI-IVF. (2002) (0)
ARTERIOSCLEROSIS IS ASSOCIATED WITH ERECTILE DYSFUNCTION IN TYPE 2 DIABETIC RATS (2008) (0)
Book ReviewPercutaneous Renal Surgery (1984) (0)
1013: Aging Related Corporaveno-Occlusive Dysfunction in Rat is Ameliorated by Piogutazone (2006) (0)
Testosterone Action, Deficiency, Substitution (2005) (0)
Urethral reconstruction before renal transplantation. (1983) (0)
T07-P-05 Time course for first successful intercourse attempt in 343 men with erectile dysfunction administered tadalafil or placebo once daily (2008) (0)
031 Collagenase Injection Into the Peyronie’s Disease-Like Plaque in A Rat Model Reduces not Just Plaque Size, but Selectively Myofibroblast Content, and is Associated With Increased Apoptosis, Replicating the Effects of A PDE5 Inhibitor Given Separately, but not in Combination (2017) (0)
TESTICULAR BLOOD FLOW ASSESSMENT WITH Xe‐133: MEASUREMENTS IN RATS.: P33 (1988) (0)
Editorial comment. (2013) (0)
167 Improvement in SHIM Scores with the iNOS Stimulator, Revactin® (2019) (0)
Decreasing Hospitalization of the Cyclosporine Treated Renal Allograft Recipient (1987) (0)
The effects of phosphodiesterase-5 inhibitors in men with "normal" erectile function. (2004) (0)
Best of the AUA Annual Meeting: Highlights From the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DC. (2011) (0)
Cadaveric renal transplantation: surgical results and expectations in the cyclosporine era. (1988) (0)
The Surgical Management of Male Infertility (1984) (0)
The y chromosome and infertility. (2001) (0)
Book Review Impotence: Diagnosis and Management of Male Erectile Dysfunction Edited by Roger S. Kirby, Culley Carson, and George D. Webster. 262 pp., illustrated. Boston, Butterworth-Heinemann, 1992. $115. 0-7506-1362-9 (1993) (0)
The Relationship between Systemic Hypertension and Erectile Dysfunction (2015) (0)
056 Dyslipidemia but Not Hyperglycemia Appears as the Main Factor Damaging Muscle Derived Stem Cells and their Tissue Repair Capacity by Long-term Exposure to a Type 2 Diabetic Milieu (2017) (0)
The Turner biopsy needle facilitates seminal vesicle aspiration. (1997) (0)
Best of the 2013 AUA Annual Meeting Part II: More Highlights From the 2013 American Urological Association Annual Meeting, May 4-8, 2013, San Diego, CA. (2013) (0)
Testosterone therapy in men with localized prostate cancer. (2008) (0)
When is azoospermia not azoospermia? (2008) (0)
Decreasing initial hospitalization of the cyclosporine-treated renal allograft recipient is safe. (1988) (0)
Focus on sexual dysfunction, tissue engineering, gene therapy: highlights from the first fall meeting of the society for the study of impotence october 1-3, 1999, Boston. (2000) (0)
849: Incidence and Clinical Recurrence of Pathologic Stage T0 Prostate Cancer in a Modern Radical Prostatectomy Series (2004) (0)
An approach to the renal transplant recipient with persistent one-month graft nonfunction. (1989) (0)
Ejaculation-the long and short of it. (2009) (0)
, E.A. Tanagho, T.F. Lue, R.D. McClure. The Williams & Wilkins Co., Baltimore (1988), 386 (1989) (0)
943: Plasminogen Activator Inhibitor 1 (PAI-1) is Increased in Human Peyronie's Disease (2005) (0)
Impact of androgen deficiency on sexual dysfunction (2007) (0)
Is TESA Passé? (2006) (0)
This Month in Investigative Urology: The Gubernaculum and Testicular Descent (1989) (0)
891 SILDENAFIL PROMOTES SMOOTH MUSCLE PRESERVATION AFTER BILATERAL CAVERNOSAL NERVE RESECTION THROUGH ACTIVATION OF ANGIOGENESIS RELATED PATHWAYS (2010) (0)
169 COMP-4 Reduces Oxidative Stress Markers in the Rat Corpora Cavernosa and Media of the Penile Dorsal Artery (2020) (0)
Traumatic Injuries of the Genitourinary System (1981) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jacob Rajfer?

Jacob Rajfer is affiliated with the following schools:

Jacob Rajfer's Academic­Influence.com Rankings

Why Is Jacob Rajfer Influential?

Jacob Rajfer's Published Works

Published Works

What Schools Are Affiliated With Jacob Rajfer?

Jacob Rajfer's AcademicInfluence.com Rankings